USA: New peanut allergy drug may prevent severe reactions
Scientists in the US are developing a drug which may help prevent serious allergic reactions in those with peanut allergies. The drug, TNX-901, which is at least three years away from going on the market, is designed to block the action of immunoglobulin-E, or IgE, a molecule that plays a major part in asthma and allergies, reports BBC News Online.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 17 years of archives.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Why personalisation will take-off in US food
- US food next wave on display at Winter Fancy Food
- Comment: Meal kits in US - don't believe the hype
- General Mills sales woes continue - analysis
- Interview: The Soulfull Project's mission
- Post Holdings 'close to acquiring Weetabix'
- Kraft Heinz cuts jobs in US, Canada
- Recipe-kit firm HelloFresh launches into UK retail
- Mondelez set for union crosshairs next week
- Mondelez plays down impact of union action